Shirui Mao

Prof. Shirui Mao

School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2014 in Carbohydrate Polymers
Verified
Journal Article
Closed access
LLLiang Li
Liang Li
RNRui Ni
Rui Ni
YSYang Shao
Yang Shao
SMShirui Mao
Shirui Mao

1 January 2020 in Drug Discovery Today
Verified
Journal Article
Closed access
Qiaoyu LiuQiaoyu Liu
Qiaoyu Liu
JGJian Guan
Jian Guan
LQLu Qin
Lu Qin
XZXin Zhang
Xin Zhang
SMShirui Mao
Shirui Mao

1 March 2015 in Drug Discovery Today
Verified
Journal Article
Closed access
ZLZhenglin Liang
Zhenglin Liang
RNRui Ni
Rui Ni
JZJieyu Zhou
Jieyu Zhou
SMShirui Mao
Shirui Mao

1 January 2017 in Asian Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
LZLan Zhang
Lan Zhang
SMShirui Mao
Shirui Mao
Quality by Test was the only way to guarantee quality of drug products before FDA launched current Good Manufacturing Practice. To clearly understand the manufacture processes, FDA generalized Quality by Design (QbD) in the field of pharmacy, which is based on the thorough understanding of how materials and process parameters affect the quality profile of final products. The application of QbD in drug formulation and process design is based on a good understanding of the sources of variability and the manufacture process. In this paper, the basic knowledge of QbD, the elements of QbD, steps and tools for QbD implementation in pharmaceutics field, including risk assessment, design of experiment, and process analytical technology (PAT), are introduced briefly. Moreover, the concrete applications of QbD in various pharmaceutical related unit operations are summarized and presented.

1 May 2016 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
LLLiang Li
Liang Li
SSSiping Sun
Siping Sun
TPTHAIGARAJAN PARUMASIVAM
THAIGARAJAN PARUMASIVAM
JDJohn Denman
John Denman
TGThomas Gengenbach
Thomas Gengenbach
HCHak-Kim Chan
Hak-Kim Chan

12 April 2020 in Journal of Pharmaceutical Investigation
Verified
Journal Article
Open access
PDF file
MGMingyue Gao
Mingyue Gao
XSXin Shen
Xin Shen
SMShirui Mao
Shirui Mao
Background In nasal drug delivery system, nasal spray seems to be the most promising delivery method for both local and systemic diseases therapy. Nasal deposition behavior is the most basic and important process for nasal sprays, which is related to nasal mucociliary clearance, retention of a formulation in the nose therefore the therapeutic effect. Area covered The present paper systemically summarized and discussed the factors influencing drug deposition in the nasal cavity upon delivery via nasal sprays, including device, formulation and administration techniques. Emitted dose volume of the device, spray pattern and plume geometry, droplet size distribution and velocity of emitted droplets were important device factors influencing nasal deposition. Besides, viscosity, thixotropic property and surface tension were considered to be the formulation factors influencing nasal deposition of spray. In addition, administration technique influencing nasal deposition included head orientation, administration angle, insertion depth of spray nozzle and breathing profile. Meanwhile, the imaging methods used to predict and visualize the deposition of nasal formulation was illustrated. Expert opinion The review provided important theoretical and experimental knowledge to control the deposition pattern of nasal sprays in order to achieve better therapeutic effect in the clinic.